Novel Potential Mechanisms of Regulatory B Cell-Mediated Immunosuppression

被引:0
作者
Elina A. Zheremyan
Alina S. Ustiugova
Anastasia I. Radko
Ekaterina M. Stasevich
Aksinya N. Uvarova
Nikita A. Mitkin
Dmitry V. Kuprash
Kirill V. Korneev
机构
[1] Center for Precision Genome Editing and Genetic Technologies for Biomedicine,
[2] Engelhardt Institute of Molecular Biology,undefined
[3] Russian Academy of Sciences,undefined
[4] Faculty of Biology,undefined
[5] Lomonosov Moscow State University,undefined
[6] Moscow Institute of Physics and Technology,undefined
[7] National Research Center for Hematology,undefined
来源
Biochemistry (Moscow) | 2023年 / 88卷
关键词
regulatory B cells; immunosuppression; anti-inflammatory molecules; immune response regulation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:13 / 21
页数:8
相关论文
共 467 条
[21]  
Shibata S.(2021)Regulatory B cells: TIM-1, transplant tolerance, and rejection Immunol. Rev. 299 204-211
[22]  
Asano Y.(2021)B cells from patients with rheumatoid arthritis show conserved CD39-mediated regulatory function and increased CD39 expression after positive response to therapy J. Mol. Biol. 433 3047-3048
[23]  
Tada Y.(2019)Human adenosine deaminase 2 deficiency: a multi-faceted inborn error of immunity Immunol. Rev. 287 923-930
[24]  
Sugaya M.(2019)CD24hiCD38hi and CD24hiCD27 J. Immunol. 203 15-21
[25]  
Kadono T.(2021) human regulatory B cells display common and distinct functional characteristics Front. Immunol. 12 10-12
[26]  
Tedder T. F.(2022)Immunosuppressive mechanisms of regulatory B cells Cell Rep. 39 525-527
[27]  
Sato S.(2020)Human IL-10-producing B cells have diverse states that are induced from multiple B cell subsets J. Transl. Med. 18 139-140
[28]  
Inoue S.(2022)Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases Front. Immunol. 13 2602-2615
[29]  
Leitner W. W.(2016)Deconvolution of B cell receptor repertoire in Multiple Sclerosis patients revealed a delay in tBreg maturation Sci. Rep. 6 193-205
[30]  
Golding B.(2019)PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer Sci. Rep. 9 180-195